CSEMOP2 - Long-Term Effects of Palopegteriparatide on BMD and TBS in Adults With Chronic Hypoparathyroidism: Pooled Results From the PaTH Forward and PaTHway Trials

Diabetes Canada/CSEM Professional Conference · 20 November 2026 · 15:15–16:30 · East Meeting Rm1 & 2 &3

CSEMOP2 - Long-Term Effects of Palopegteriparatide on BMD and TBS in Adults With Chronic Hypoparathyroidism: Pooled Results From the PaTH Forward and PaTHway Trials was a session at Diabetes Canada/CSEM Professional Conference on 20 November 2026 in Vancouver, with 1 speaker on record.

Speakers

• Aliya A. Khan — Speaker Canadian Ambassador, American Society for Bone and Mineral Research (ASBMR)